NCT04987151 The Effects of Different Modalities of Exercise in Patients With Schizophrenia Status UNKNOWN Phase NA
NCT04975035 A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine Status TERMINATED Phase PHASE1/PHASE2
NCT04972227 Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia Status COMPLETED Phase PHASE1
NCT04968223 Neural Correlates of Social Touch and Interoceptive Perception As Potential Biomarker for Impaired Social Functioning Status COMPLETED Phase N/A
NCT04959201 Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia Status RECRUITING Phase PHASE2
NCT04959032 Lumateperone for the Prevention of Relapse in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT04951700 Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04946916 Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease Status RECRUITING Phase NA
NCT04941677 Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control Status COMPLETED Phase N/A
NCT04940663 Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness Status RECRUITING Phase NA
NCT04940039 A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings Status COMPLETED Phase PHASE4
NCT04929795 Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients Status COMPLETED Phase NA
NCT04922593 Relative Bioavailability of LY03010 Compared to Listed Drug Status COMPLETED Phase PHASE1
NCT04917302 Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia Status RECRUITING Phase PHASE2
NCT04916626 The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT04911010 Effectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic Disorder Status UNKNOWN Phase NA
NCT04892199 Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Status ACTIVE_NOT_RECRUITING Phase PHASE4